Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBF)

254.60
Delayed Data
As of Sep 21
 0.00 / 0.00%
Today’s Change
243.50
Today|||52-Week Range
275.70
-6.91%
Year-to-Date
BioLineRx Begins Trial on BL-8040/ Keytruda Combination
Sep 21 / Zacks.com - Paid Partner Content
Roche Ocrevus Positive in Phase III Multiple Sclerosis Trials
Sep 15 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's NDA Accepted for Review, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
How Risky Is Organovo Holdings, Inc.?
Sep 12 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close254.60
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)76
Market cap$40.7B
Dividend yield3.19%
Data as of 09/21/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts

Chart unavailable

Search for Jobs